Catalyst Wire Dossier Catalyst Wire Dossier

Plixorafenib

plixorafenib · Fore Biotherapeutics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Plixorafenib, covering 2026-03-27 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma [EARLY_Phase 1]

See pricing